Full Event Guide - 17th World ADC San Diego | October

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

See Who's Attending, What Data Is Being Presented & Why 1,300+ ADC Leaders Will Be in San Diego

The 17^th World ADC San Diego is the largest, longest standing and premier ADC forum, acting as the pivotal ADC orientation point for top pharma and biotech, innovative start-ups, leading service providers and academic, physician and regulator KOLs to harness ADC innovation and redefine the precision oncology landscape.

Download the official Event Guide to get an inside look at the science, speakers, companies, and networking opportunities shaping the future of ADC development. Explore the agenda, discover who's already confirmed to attend, and see why more than 1,300 ADC leaders from 400+ organizations will gather in San Diego this October.

17th World ADC San Diego Summit Brochure

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Fresh Perspectives: First-Time Companies Taking the Stage in 2026

The Features Driving Record Attendance

1,300+

ADC Industry Attendees

400+

Attending Companies

170+

World-Class Speaker Faculty

17

Hours of Structured & Informal Networking

2

All-Day Scientific Poster Sessions

12%

Private Meeting Adoption Rate

13

Years of Celebrating the World ADC Awards